The Histology and Cytology Consumables Market Size is valued at USD 7.99 Bn in 2022 and is predicted to reach USD 17.24 Bn by the year 2031 at a 9.1% CAGR during the forecast period for 2023-2031.
Histology and cytology are key areas of research in the medical world that diagnose disorders in organs, tissues, and physiological fluids. Histology and cytology are essential components of pathology, and because of ongoing research and development and technological developments, their use is predicted to skyrocket in the future decade. Advances in digital pathology are expected to pave the way for innovations, data collection techniques, and diagnostic treatment over the next few years, resulting in a bright future for the worldwide histology & cytology market.
The rise in the prevalence of age-related chronic diseases such as cancer, as well as the growing use of immunohistochemistry for visualizing cellular components to diagnose a variety of diseases, are driving market expansion.
However, non-urgent medical treatments, including histology and cytology exams, may have been delayed or curtailed during the pandemic's height to prioritize resources for COVID-19 patients. This could have resulted in a brief drop in demand for associated consumables.
Competitive Landscape
Some major key players in the Histology and Cytology Consumables Market:
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Abbott Laboratories
- Becton Dickinson and Company
- Hoffmann-La Roche Ltd
- Promega Corporation
- Agilent Technologies Inc.
- Roche Holding AG
- Merck KGaA
- Allergan, Plc.
- PerkinElmer, Inc.
- Hologic, Inc.
- Trivitron Healthcare
- Sysmex Corporation
- Koninklijke Philips N.V.
Market Segmentation:
The Histology and Cytology Consumables Market is divided into product, application and end-user. As per the product type, the market is segmented as kits & reagents, enzymes, stains & dyes, and others. The application segment includes molecular diagnostic study, cell signalling, clinical diagnosis, epigenetics & sequencing study, and other applications. The segment end-user consists of hospitals, diagnostics centres, the biotechnology & pharmaceutical industry, academic research institutes, and other end-users.
Based On Product Type, The Kits & Reagents Segment Is Accounted As A Major Contributor In The Histology And Cytology Consumables Market
The kits & reagents category is expected to hold a major share of the global Histology and Cytology Consumables Market in 2022. The ongoing advancement of new diagnostic technologies, such as automated staining systems and digital pathology solutions, stimulates the demand for specialized kits and reagents compatible with these technologies. The rising frequency of chronic diseases, particularly cancer, feeds the demand for precise and efficient diagnostic procedures, necessitating the development of sophisticated staining and analysis kits.
The Clinical Diagnosis Segment Witnessed Growth At A Rapid Rate.
The clinical diagnosis segment is projected to grow at a rapid rate in the global Histology and Cytology Consumables Market. The rising cancer incidence fuels the need for precise histological and cytological diagnostics for early identification, staging, and therapy planning. The increase in the number of well-equipped clinical laboratories, as well as favourable reimbursement for cancer screening and laboratory testing, are driving market expansion.
In The Region, The North American Histology And Cytology Consumables Market Holds A Significant Revenue Share.
The North American histology and Cytology Consumables Market is likely to register the maximum market share in terms of revenue in the near future. The high prevalence of cancer, intensive R&D efforts, the presence of significant organizations, and the developed research infrastructure for pathology services are only a few of the elements that have contributed to the region's rise. The market for histology and cytology is also expanding as a result of the high rate of product approval and commercialization in the area.
Asia Pacific is also estimated to experience rapid growth in the upcoming years. A big target population, increasing cancer awareness, and improved healthcare infrastructure are just a few of the elements contributing to the region's rise. The market for histology and cytology in the region is also expanding as a result of researchers' increased evaluation of novel cytology.
Histology and Cytology Consumables Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 7.99 Bn |
|
Revenue Forecast In 2031 |
USD 17.24 Bn |
|
Growth Rate CAGR |
CAGR of 9.1% from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, Application, End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Thermo Fisher Scientific, Inc., Danaher Corporation, Abbott Laboratories, Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Promega Corporation, Agilent Technologies Inc., Roche Holding AG, Merck KGaA, Allergan, Plc, PerkinElmer, Inc., Hologic, Inc., Trivitron Healthcare, Sysmex Corporation, Koninklijke Philips N.V.and others. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
